Let’s Talk Medtech

Exploring FDA's Stance on LDTs & AI

Dec 12, 2023
Regulatory updates on laboratory-developed tests, artificial intelligence, and software discussed by an attorney. Mintz's role in helping medical device companies navigate FDA regulations, including AI and machine learning-enabled software. Importance of understanding FDA regulations for medical devices and software. Discussion on expectations for FDA's final rule on LDTs & AI. Impact of the EUMDR on companies and confusion surrounding compliance. Concluding thoughts on changing regulatory landscape.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Role of Mintz in FDA regulatory pathways and strategies for medical device companies
01:31 • 2min
3
Understanding FDA Regulations for Medical Devices and Software
03:03 • 20min
4
Expectations and Challenges Ahead for FDA's Final Rule on LDTs & AI
22:42 • 3min
5
Navigating the European Union Medical Device Regulation
25:32 • 7min
6
Closing Thoughts and Contact Information
32:34 • 2min